On 2025-05-08, Amylyx Pharmaceuticals, Inc. (AMLX) announced earnings per share of $-0.42 for the fiscal quarter ending 2025-03-31, beating the average analyst estimate of $-0.45.
The next expected annoucement date for quarterly earnings is 2025-08-14, with an average estimated earnings per share of $-0.43 for the fiscal quarter ending 2025-06-30.
Note: Earnings figures are calculated as diluted earnings per share before non-recurring items and including employee stock options expenses.
| Announcement Date | Fiscal Quarter End | Estimated EPS | Actual EPS |
|---|---|---|---|
| 2025-05-08 | 2025-03-31 | $-0.45 | $-0.42 |
| 2025-03-04 | 2024-12-31 | $-0.49 | $-0.55 |
| 2024-11-07 | 2024-09-30 | $-0.47 | $-0.53 |
| 2024-08-08 | 2024-06-30 | $-0.38 | $-0.73 |
| 2024-05-09 | 2024-03-31 | $0.24 | $-0.46 |
| 2024-02-22 | 2023-12-31 | $0.20 | $0.07 |
| 2023-11-09 | 2023-09-30 | $0.42 | $0.30 |
| 2023-08-10 | 2023-06-30 | $0.01 | $0.31 |
| 2023-05-11 | 2023-03-31 | $-0.27 | $0.02 |
| 2023-03-13 | 2022-12-31 | $-0.77 | $-0.65 |
| 2022-11-10 | 2022-09-30 | $-0.97 | $-0.92 |
| 2022-08-11 | 2022-06-30 | $-0.92 | $-0.93 |
| 2022-05-12 | 2022-03-31 | $-0.75 | $-0.93 |